Optimism about the arrival of the Russian vaccine in Argentina – Radioinforme 3

As indicated, Sputnik V integrates a batch of 10 different vaccines having passed phases 1 and 2 and undergoes this last phase of testing where it must verify its effectiveness.

“In phase 1, what is examined is the security, in the 2 which arouses the immune response of antibody and in 3 it is determined Efficiency. This phase 3 involves massively between 40,000 and 60,000 people ”, he recalled.

/ Embedded code reception /

/ End of embed code /

In this regard, he said that the Russian vaccine has already passed phases 1 and 2 and published these results in the prestigious magazine The Lancet, But there are no published results yet for phase 3 of any of the vaccines tested.

“Phase 3 involves you finishing vaccinating those thousands of people and having to wait a few months to see who is infected and who is not, and it will be end of November», He stressed.

The massive application is not complete and it will not be until the results are available, which must first be published

Regarding the risks of this vaccine, Geffner said “it is minimal”, although what really worries is the effectiveness. Meanwhile, countries buy at risk to secure stocks.

“The vaccines are designed to be safe, there are many and different, but we don’t know how effective they are, if it will protect 60% or 70% and how long that immunity will last,” he said.

“Today, thousands of people are vaccinated and the effects of contagion reports have been sporadic. But I want to see the effectiveness and that is why I need the results of the third phase, ”he concluded.

Interview with Miguel Clariá.